Provides a foundational map of transcriptional and cellular diversity in the normal human heart to facilitate future cardiovascular therapeutic development.
Using large-scale single nuclei RNA sequencing, we defined the transcriptional and cellular diversity in the normal human heart. Our identification of discrete cell subtypes and differentially expressed genes within the heart will ultimately facilitate the development of new therapeutics for cardiovascular diseases.
Tucker et al. (Thu,) studied this question.